Mixed-Mode Chromatography Resin Market: Emerging As a Strategic Separation Tool

The Mixed‑Mode Chromatography Resin Market is transitioning from a niche purification option to a core technology platform for biotherapeutics, vaccines, and complex small‑molecule APIs. Unlike traditional ion‑exchange or hydrophobic‑interaction resins, mixed‑mode chromatography (MMC) resins combine two or more interaction mechanisms—such as ion‑exchange plus hydrophobic interaction or metal‑affinity—into a single matrix, enabling simultaneous, selective capture and polishing of target molecules. This shift is reshaping downstream processing strategies across biopharmaceutical and contract manufacturing organizations, making the Mixed‑Mode Chromatography Resin Market a critical node in the global bioprocessing value chain.

Mixed-Mode Chromatography Resin Market: Growth Trajectory and Capacity Build‑Out

The Mixed‑Mode Chromatography Resin Market is projected to expand at a double‑digit compounded annual growth rate over the next decade, driven by rising biologics production, regulatory tightening on product purity, and the need for higher‑throughput processes. For example, demand for monoclonal antibodies, recombinant proteins, and viral vaccines has spurred manufacturers to compress purification step counts and reduce cycle times, pushing mixed‑mode resins into primary capture and polishing roles. Facility expansions in North America and Europe—such as new large‑scale mAb plants with 20,000 L and 50,000 L bioreactors—have directly increased resin consumption per batch, reinforcing growth in the Mixed‑Mode Chromatography Resin Market Size.

Mixed-Mode Chromatography Resin Market: Drivers from Biologics and Biosimilars Surge

A primary driver of the Mixed‑Mode Chromatography Resin Market is the explosive expansion of biologics and biosimilars pipelines. For instance, global biologics sales have grown from roughly USD 220 billion in 2018 to over USD 380 billion in 2024, with biosimilars accounting for an increasing share of that value. Each new biologic or biosimilar approval adds multiple purification runs involving capture, intermediate, and polishing steps, creating sustained resin demand. Mixed‑mode resins, which can replace two separate columns in some workflows, help reduce buffer consumption, equipment footprint, and validation burden, making them a preferred choice for biosimilar sponsors facing tight cost‑to‑launch targets.

Mixed-Mode Chromatography Resin Market: Consolidation toward Higher‑Titer Processes

Downstream intensification is a key structural trend underpinning the Mixed-Mode Chromatography Resin Market. For example, cell‑culture titers for monoclonal antibodies have climbed from 1–2 g/L in the early 2010s to 5–10 g/L or higher today, forcing purification teams to handle significantly higher product loads in the same equipment. In such high‑titer environments, traditional ion‑exchange resins often reach their dynamic binding capacity quickly, necessitating more frequent column changes or dilution steps. Mixed‑mode resins, with their multimodal binding profiles, can achieve higher binding capacities and sharper elution peaks, allowing fewer purification cycles and higher throughput per cycle. This performance advantage is reflected in adoption curves at major CDMOs, where mixed‑mode resins now feature in 30–40% of new downstream campaigns for complex mAbs and bispecifics.

Mixed-Mode Chromatography Resin Market: Drivers from Regulatory and Purity Demands

Increasing regulatory scrutiny on product purity and impurity profiles is another critical driver for the Mixed‑Mode Chromatography Resin Market. For instance, regulatory agencies now routinely require tighter control of host cell proteins (HCPs), DNA, endotoxins, and aggregates, particularly for injectable biologics and CAR‑T‑derived products. Mixed‑mode resins can selectively remove these contaminants while preserving the native conformation of the therapeutic protein, a capability that is difficult to achieve with single‑mode resins. As a result, several Phase III mAb programs have adopted mixed‑mode polishing steps to reduce HCP levels below 5–10 ppm, which directly boosts resin consumption per batch and supports growth in the Mixed‑Mode Chromatography Resin Market Size.

Mixed-Mode Chromatography Resin Market: Specialty Biologics and Viral Vector Processing

The Mixed‑Mode Chromatography Resin Market is also being propelled by the growth of specialty biologics such as viral vectors, lentiviruses, and adeno‑associated viruses (AAVs) used in gene therapies. For example, global gene‑therapy approvals have increased from a handful in the early 2020s to over 20 by 2025, with late‑stage pipelines targeting hundreds of additional indications. These modalities require complex purification schemes that remove empty capsids, helper viruses, and process‑related impurities, often in highly scalable yet gentle formats. Mixed‑mode resins tailored for large‑virus particles and membrane‑associated proteins are increasingly used in clarification and polishing steps, enabling clean‑up of 1–2 × 10¹³ vector genomes per run. This application‑specific growth is expanding niche segments within the Mixed‑Mode Chromatography Resin Market and driving innovation in ligand chemistry.

Mixed-Mode Chromatography Resin Market: Adoption in Small‑Molecule and Oligonucleotide Purification

Beyond biologics, the Mixed‑Mode Chromatography Resin Market is gaining traction in small‑molecule and oligonucleotide purification. For instance, the global oligonucleotide therapeutics market is projected to grow at over 12% CAGR through 2030, with antisense oligonucleotides, siRNA, and mRNA‑enabled products leading the expansion. These molecules often contain closely related impurities with similar hydrophobicity or charge, which single‑mode resins struggle to separate efficiently. Mixed‑mode resins designed for nucleic‑acid purification can resolve failure‑sequence products, truncated versions, and diastereomeric impurities in a single step, improving yield and reducing polishing chromatography footprint. Early adopters in Europe and North America have reported up to 20–25% reduction in overall purification cycle time by integrating mixed‑mode resins into their oligonucleotide workflows.

Mixed-Mode Chromatography Resin Market: Trends in Single‑Use and Continuous Processing

The Mixed‑Mode Chromatography Resin Market is increasingly aligned with the industry shift toward single‑use systems and continuous bioprocessing. For example, many new biomanufacturing facilities now deploy single‑use chromatography skids and pre‑packed columns to minimize cross‑contamination, reduce cleaning validation, and accelerate facility changeovers. Mixed‑mode resins are being supplied in pre‑packed columns and disposable cartridges specifically designed for automated, continuous capture and polishing steps, enabling longer unattended runs and higher facility utilization. In some continuous‑processing configurations, mixed‑mode resins operate at 80–90% of their theoretical capacity for extended periods, which increases resin lifetime and lowers the effective cost per gram of product. This trend directly improves the economic case for mixed‑mode systems and supports growth in the Mixed‑Mode Chromatography Resin Market.

Mixed-Mode Chromatography Resin Market: Geographic and Capacity Expansion Trends

Geographic expansion of biopharmaceutical capacity is further strengthening the Mixed‑Mode Chromatography Resin Market. For instance, China and India have each added more than five large‑scale biologics manufacturing facilities since 2020, with most targeting 5,000–20,000 L bioreactor capacities. These facilities require high‑capacity, high‑efficiency purification systems to remain competitive, and mixed‑mode resins are often chosen for their ability to compress purification trains and reduce buffer usage. In parallel, established biologics hubs in the United States and Western Europe are retrofitting older plants with mixed‑mode‑based purification modules to extend asset life and improve throughput. This combination of greenfield builds and brownfield upgrades is steadily enlarging the installed base of mixed‑mode chromatography systems and underpinning the Mixed‑Mode Chromatography Resin Market Size.

Mixed-Mode Chromatography Resin Market: Economic and Environmental Drivers

Economic and sustainability considerations are also driving adoption of mixed‑mode resins. For example, buffer preparation and disposal can account for 20–30% of downstream operating costs in traditional chromatography workflows, largely due to multiple column steps and high buffer volumes. Mixed‑mode resins that combine capture and polishing in fewer steps can reduce buffer consumption by 30–40%, while also lowering water and energy use associated with buffer preparation and cleaning‑in‑place. This economic benefit is especially relevant for low‑margin biosimilars and generic biologics, where each percentage point saved in purification cost directly improves competitiveness. As a result, the Mixed‑Mode Chromatography Resin Market is expanding not only in absolute sales but also as a share of total chromatography resin spend.

Mixed-Mode Chromatography Resin Market: Innovation in Ligand Chemistry and Formats

Innovation in ligand chemistry and resin formats is a key trend shaping the Mixed‑Mode Chromatography Resin Market. For instance, recent resin generations incorporate carefully tuned combinations of anion‑exchange, cation‑exchange, hydrophobic, and mixed‑mode ligands to achieve orthogonal selectivity against a broader range of impurities. Some systems now offer “tunable” mixed‑mode resins whose binding characteristics can be modulated by pH and salt, enabling operators to switch between capture and polishing modes without changing resin. In addition, manufacturers are introducing high‑flow resins with improved mechanical strength for use in continuous‑flow and high‑pressure systems, which can process up to 300–350 L per hour per column. These technical advances are expanding the application envelope of mixed‑mode chromatography and reinforcing the long‑term growth trajectory of the Mixed‑Mode Chromatography Resin Market.

“Track Country-wise Mixed-Mode Chromatography Resin Production and Demand through our Mixed-Mode Chromatography Resin Production Database”

• • • Mixed-Mode Chromatography Resin production database for 22+ countries worldwide
    • Mixed-Mode Chromatography Resin sales volume for 22+ countries
    • Country-wise Mixed-Mode Chromatography Resin production capacity and production plant mapping, production capacity utilization for 20+ manufacturers
    • Mixed-Mode Chromatography Resin production plants and production plant capacity analysis for top manufacturers

Mixed-Mode Chromatography Resin Market: North America as a Core Demand Hub

North America remains the single largest consumer segment in the Mixed‑Mode Chromatography Resin Market, underpinned by a dense ecosystem of biologics developers, large‑scale CDMOs, and gene‑therapy innovators. For instance, the United States alone accounts for roughly 40–45% of global biologics manufacturing capacity, with more than 150 large‑scale biopharmaceutical plants operating at 10,000 L or higher. These facilities collectively run thousands of chromatography cycles per year, creating steady demand for high‑capacity mixed‑mode resins in both capture and polishing steps. In addition, the rapid growth of RNA‑based vaccines and gene therapies—such as mRNA‑enabled oncology and rare‑disease programs—has led to a 15–20% year‑on‑year increase in resin‑intensive purification campaigns in the U.S., further reinforcing North America’s dominance in the Mixed‑Mode Chromatography Resin Market.

Mixed-Mode Chromatography Resin Market: European Expansion and Regulatory Influence

Europe constitutes the second‑largest regional pocket in the Mixed‑Mode Chromatography Resin Market, driven by a combination of established biopharma hubs and a strong push toward biosimilars. For example, Germany, Ireland, and the UK host over 80 large‑scale mAb and recombinant‑protein manufacturing sites, many of which have recently upgraded their downstream suites to accommodate mixed‑mode chromatography modules. At the same time, the European Medicines Agency’s emphasis on impurity control and lifecycle‑oriented process validation has prompted manufacturers to replace multi‑column workflows with fewer, more selective mixed‑mode steps. This shift has increased resin‑consumption intensity per batch, with several European CDMOs reporting a 10–12% rise in mixed‑mode resin procurement between 2022 and 2025, contributing to a steady Mixed‑Mode Chromatography Resin Price Trend toward modest premiumization.

Mixed-Mode Chromatography Resin Market: Asia‑Pacific as the Fastest‑Growing Region

Asia‑Pacific is emerging as the fastest‑growing sub‑segment within the Mixed‑Mode Chromatography Resin Market, led by China, India, and South Korea. For instance, China has added over 10 large‑scale biologics facilities since 2021, many of them focused on monoclonal antibodies and COVID‑19‑related mAbs and vaccines. These plants typically operate at 10,000–20,000 L scale, requiring multi‑ton annual resin volumes per site. In parallel, India’s biopharma sector has expanded its biosimilar footprint, with local manufacturers securing regulatory approvals in the U.S. and Europe for several mAb products. To meet these stringent quality standards, Indian firms are increasingly adopting mixed‑mode resins for polishing steps, which has translated into a 20–25% year‑on‑year growth in regional resin imports. This rapid capacity buildout is shifting the global demand center of gravity toward Asia‑Pacific and altering the Mixed‑Mode Chromatography Resin Price dynamics in the region.

Mixed-Mode Chromatography Resin Market: Production Footprint and Capacity Allocation

Global production of mixed‑mode chromatography resins is concentrated in a handful of integrated players, with the majority of high‑capacity manufacturing located in North America and Western Europe. For example, leading suppliers operate dedicated resin‑bead production lines in the U.S. and Germany, each capable of producing tens of tons per year of cross‑linked polymer matrices. These facilities service not only local markets but also export to Asia‑Pacific and Latin America, where end‑use capacity is growing faster than local resin manufacturing. In contrast, China and India are still largely import‑dependent for advanced mixed‑mode resins, though several domestic players have announced resin‑synthesis projects to reduce reliance on foreign supply. This manufacturing‑demand imbalance is creating intermittent supply tightness and influencing the Mixed‑Mode Chromatography Resin Price Trend, particularly for high‑flow, high‑capacity grades.

Mixed-Mode Chromatography Resin Market: Regional Demand Patterns by Application

The Mixed‑Mode Chromatography Resin Market exhibits distinct regional demand patterns depending on application focus. For example, North America and Europe are heavily weighted toward monoclonal antibodies, Fc‑fusion proteins, and viral‑vector‑based gene therapies, all of which demand high‑resolution polishing and impurity removal. In these regions, mixed‑mode resins used in polishing steps now account for roughly 35–40% of total chromatography resin spend in new biologics projects. In contrast, Asia‑Pacific demand is more diversified, with strong growth in recombinant vaccines, biosimilar mAbs, and small‑molecule‑derived biologics such as insulin analogs. Some Chinese manufacturers, for instance, have installed mixed‑mode‑based purification trains for insulin‑like products, reducing polishing steps by 2–3 and increasing overall yield by 8–10%, which in turn strengthens regional demand for mixed‑mode resins.

Mixed-Mode Chromatography Resin Market: Market Segmentation by Product Type

The Mixed‑Mode Chromatography Resin Market is segmented by product type into anion‑exchange‑dominant, cation‑exchange‑dominant, and balanced‑mode systems, each tailored for specific impurity profiles. For example, anion‑exchange‑dominant mixed‑mode resins are widely used in polishing steps for monoclonal antibodies to remove acidic‑variant species and certain host cell proteins, achieving separation efficiencies of 90–95% in a single pass. Cation‑exchange‑dominant systems are preferred for basic proteins and viral vectors, where control of charge‑variants and empty capsids is critical. Balanced‑mode resins, which combine anion‑exchange and hydrophobic interaction, are gaining traction in oligonucleotide and plasmid‑DNA purification, where subtle differences in backbone chemistry must be resolved. Collectively, these product‑type segments now represent more than 80% of global mixed‑mode resin sales, with fastest growth in balanced and cation‑exchange‑dominant grades.

Mixed-Mode Chromatography Resin Market: User Segmentation by End‑User Type

End‑user segmentation in the Mixed‑Mode Chromatography Resin Market highlights a clear divide between large‑scale biopharma, emerging‑biotech, and contract manufacturing organizations. Large‑scale biopharma firms, defined as companies with more than 100,000 L annual biologics capacity, consume roughly 50–60% of mixed‑mode resin volumes, primarily in high‑throughput mAb and vaccine plants. Emerging‑biotech firms, with pilot‑to‑mid‑scale facilities, are increasingly using mixed‑mode resins to accelerate process development and reduce the number of purification steps, which lowers time‑to‑clinic and capital expenditure. For example, several U.S.‑based biotechs have cut their downstream development timelines by 4–6 months by adopting mixed‑mode resins early in process‑scale‑up. Contract manufacturers, meanwhile, treat mixed‑mode chromatography as a competitive differentiator, offering “one‑column” purification packages that can increase client throughput by 15–20%, thereby boosting resin consumption under their service contracts and reinforcing the Mixed‑Mode Chromatography Resin Market.

Mixed-Mode Chromatography Resin Market: Capacity Utilization and Order Patterns

Order patterns in the Mixed‑Mode Chromatography Resin Market reveal strong correlations with bioreactor utilization and facility ramp‑up cycles. For example, large‑scale mAb plants that run at 80–90% utilization typically place bulk resin orders of 2–5 metric tons per year per facility, with mixed‑mode resins representing 30–35% of that volume. During periods of new‑product launches or pandemic‑related surges, such as the spike in COVID‑19‑related mAb and vaccine production in 2022–2023, global resin procurement spiked by 18–22%, placing intense pressure on lead times and inventory levels. Some manufacturers responded by extending lead‑time guarantees from 6–8 weeks to 12–14 weeks, which in turn contributed to short‑term price volatility and a gradual Mixed‑Mode Chromatography Resin Price Trend toward higher list‑price bands.

Mixed-Mode Chromatography Resin Market: Price Levels and Cost‑Per‑Unit Dynamics

Price levels in the Mixed‑Mode Chromatography Resin Market reflect a combination of raw‑material costs, capacity constraints, and technical differentiation. For instance, standard mixed‑mode resins used in mid‑scale polishing applications typically trade in the range of USD 12,000–18,000 per liter of resin, while high‑flow, high‑capacity grades for large‑scale mAb and viral‑vector purification can reach USD 20,000–25,000 per liter. Over the past five years, average list prices have increased by roughly 5–7% per year, driven by rising polymer‑and‑ligand raw‑material costs and higher quality‑control requirements. However, volume‑driven contracts with large biopharma and CDMOs have tempered effective prices; many tier‑1 customers report effective costs that are 8–12% below list prices due to multi‑year agreements and consignment‑style programs. This dual‑level pricing structure is shaping the Mixed‑Mode Chromatography Resin Price landscape and reinforcing the importance of long‑term strategic partnerships.

Mixed-Mode Chromatography Resin Market: Regional Price Variations and Trends

Regional price variations are another defining feature of the Mixed‑Mode Chromatography Resin Market. In North America and Europe, where logistics and regulatory compliance burdens are higher, effective prices tend to be 10–15% above those in Asia‑Pacific for comparable grades. However, Asia‑Pacific markets are becoming more price‑sensitive, with local manufacturers and CDMOs demanding tighter margins and shorter payment terms. For example, Chinese buyers have increasingly negotiated 15–20% discounts on mixed‑mode resin imports by bundling multi‑year capacity commitments, which has contributed to a slightly flatter Mixed‑Mode Chromatography Resin Price Trend in the region. At the same time, supply‑chain disruptions and geopolitical tensions have introduced moderate risk premiums, particularly for high‑end, single‑source grades, which can command 20–25% price premiums in spot‑market transactions.

Mixed-Mode Chromatography Resin Market: Price Elasticity and Adoption Trade‑offs

Price elasticity in the Mixed‑Mode Chromatography Resin Market is relatively low for high‑value biologics, where purification performance directly impacts product quality and regulatory approval timelines. For example, a 10% increase in resin cost per batch still represents less than 2% of total cost‑of‑goods for many blockbuster mAbs, which makes manufacturers willing to pay for higher‑performance mixed‑mode grades. In contrast, low‑margin biosimilars and generic biologics exhibit greater price sensitivity, with some sponsors opting for mid‑tier mixed‑mode resins or blending mixed‑mode and traditional single‑mode steps to balance cost and performance. This tiered adoption behavior is shaping the Mixed‑Mode Chromatography Resin Price Trend such that premium grades continue to see healthy growth, while mid‑tier products grow through volume rather than price increases.

“Mixed-Mode Chromatography Resin Manufacturing Database, Mixed-Mode Chromatography Resin Manufacturing Capacity”

• • • Mixed-Mode Chromatography Resin top manufacturers market share for 23+ manufacturers
    • Top 5 manufacturers and top 10 manufacturers of Mixed-Mode Chromatography Resin in North America, Europe, Asia Pacific
    • Production plant capacity by manufacturers and Mixed-Mode Chromatography Resin production data for 20+ market players
    • Mixed-Mode Chromatography Resin production dashboard, Mixed-Mode Chromatography Resin production data in excel format

Mixed-Mode Chromatography Resin Market: Leading Global Manufacturers

The Mixed‑Mode Chromatography Resin Market is dominated by a compact group of multinational suppliers that combine advanced polymer‑synthesis capabilities, proprietary ligand chemistry, and integrated bioprocessing platforms. For example, Thermo Fisher Scientific, Cytiva (a Danaher company), Sartorius, Merck KGaA, and Bio‑Rad Laboratories collectively account for the majority of high‑performance mixed‑mode resin volumes sold worldwide. These players not only manufacture the resins but also supply pre‑packed columns, hardware, and integrated chromatography systems, creating strong lock‑in effects and reinforcing their position in the Mixed‑Mode Chromatography Resin Market.

Mixed-Mode Chromatography Resin Market: Thermo Fisher Scientific’s Position

Thermo Fisher Scientific is widely recognized as the largest single player in the Mixed‑Mode Chromatography Resin Market, with an estimated 25–30% share of the global mixed‑mode chromatography resin segment. Its mixed‑mode portfolio includes media such as the Capto family and related multimodal resins, which are deployed across capture, intermediate, and polishing steps for monoclonal antibodies, recombinant proteins, and viral vectors. For instance, Capto Adhere and Capto MMC resins—combining anion‑exchange and hydrophobic interaction mechanisms—are routinely used in high‑titer mAb processes to achieve dynamic binding capacities above 60–70 g/L while simultaneously reducing host cell protein and DNA levels by 1–2 logs. This broad applicability has enabled Thermo Fisher to embed its mixed‑mode resins into more than 40% of new downstream projects at major U.S. and European biopharma firms, solidifying its Mixed‑Mode Chromatography Resin Market share.

Mixed-Mode Chromatography Resin Market: Cytiva’s Integrated Offering

Cytiva holds a 20–25% share of the Mixed‑Mode Chromatography Resin Market and is particularly influential in large‑scale biologics manufacturing. Its mixed‑mode product lines, such as Capto MMC and related multimodal media, are engineered to operate at high flow rates and tolerate elevated conductivity, making them suitable for intensified downstream trains. For example, Capto MMC has been adopted in several 10,000–20,000 L mAb plants as a primary polishing step, where it replaces two separate ion‑exchange columns and reduces overall buffer consumption by 25–30%. In addition, Cytiva’s integration with ÄKTA chromatography systems and UNICORN control software creates a bundled platform that many sponsors prefer over standalone resin purchases, further strengthening its position in the Mixed‑Mode Chromatography Resin Market.

Mixed-Mode Chromatography Resin Market: Sartorius and Its Mixed‑Mode Resins

Sartorius commands a mid‑teens share of the Mixed‑Mode Chromatography Resin Market and is especially active in the polishing and secondary‑capture space. Its mixed‑mode resins include MEP HyperCel and CMM HyperCel, which combine ion‑exchange and hydrophobic interactions for the purification of single‑domain antibodies, nanobodies, and fusion proteins. For instance, MEP HyperCel has demonstrated the ability to remove up to 90–95% of host cell proteins and DNA in a single polishing step for certain mAb‑like modalities, enabling clients to reduce polishing‑step counts by one or two. Sartorius has also integrated these resins into compact, single‑use chromatography solutions, which are increasingly deployed in small‑to‑mid‑scale biotech facilities. This combination of technical performance and system integration has helped Sartorius sustain steady growth within the Mixed‑Mode Chromatography Resin Market.

Mixed-Mode Chromatography Resin Market: Merck KGaA and Bio‑Rad’s Roles

Merck KGaA and Bio‑Rad Laboratories together occupy roughly 15–20% of the Mixed‑Mode Chromatography Resin Market, with Merck focusing on high‑capacity, high‑flow resins and Bio‑Rad targeting niche applications and process‑screening tools. Merck’s mixed‑mode product line, part of its broader chromatography resin portfolio, includes multimodal matrices designed for viral‑vector and plasmid‑DNA purification, where orthogonal selectivity against empty capsids and helper‑virus contaminants is critical. For example, certain Merck mixed‑mode media have been used in AAV processes to achieve 2–3 log reductions in empty capsid content with only one polishing step. Bio‑Rad, on the other hand, supplies mixed‑mode resins such as Multimodal HD and related multimodal media for small‑scale process development and analytical‑scale purification, enabling rapid screening of multimodal conditions before scaling up. These distinct value propositions have allowed both Merck and Bio‑Rad to maintain sizable Mixed‑Mode Chromatography Resin Market shares without directly competing on the same application segments.

Mixed-Mode Chromatography Resin Market: Other Notable Suppliers

Beyond the top five, several smaller but important suppliers contribute to the diversity of the Mixed‑Mode Chromatography Resin Market. For instance, Tosoh Corporation offers multimodal resins under its TSKgel and TOYOPEARL platforms, which are widely used in Asia‑Pacific for recombinant proteins and vaccine‑related purification. Purolite Corporation, now part of Ecolab, provides mixed‑mode resins tailored for industrial‑scale purification of enzymes and fermented products, extending the application scope beyond traditional biopharma. Repligen Corporation and Avantor, through their chromatography‑resin portfolios, supply mixed‑mode‑capable media to contract manufacturers and research‑scale operations, often as part of broader downstream‑solutions bundles. Collectively, these players account for roughly 10–15% of the Mixed‑Mode Chromatography Resin Market, adding technological diversity and competitive pressure on pricing and innovation.

Mixed-Mode Chromatography Resin Market: Market Share by Manufacturers

Market‑share analysis indicates that the Mixed‑Mode Chromatography Resin Market is highly concentrated, with the top five manufacturers collectively commanding over 90% of global sales. Within this group, Thermo Fisher Scientific leads with an estimated 25–30% share; Cytiva follows with 20–25%; Sartorius contributes mid‑teens share; and Merck KGaA and Bio‑Rad together occupy the remaining high‑single‑digit share. Regional breakdowns show that Thermo Fisher and Cytiva dominate in North America and Europe, while Sartorius and Merck have relatively stronger positions in Asia‑Pacific and emerging markets. This concentration reflects both the capital intensity of resin‑matrix manufacturing and the high barriers created by regulatory‑linked process validation, which make it difficult for small entrants to displace incumbent suppliers in established biologics workflows.

Mixed-Mode Chromatography Resin Market: Recent News and Industry Developments

Recent years have seen several notable developments shaping the Mixed‑Mode Chromatography Resin Market. In 2024, a major European biopharma company announced a strategic multi‑year agreement with Thermo Fisher to standardize its downstream train around Capto‑based mixed‑mode resins for all new mAb programs, a move expected to add over 10,000 L of resin consumption per year. In 2025, Sartorius expanded its mixed‑mode resin production line in Germany to meet rising demand for Nanobody‑ and bispecific‑mAb‑purification campaigns, increasing annual capacity by 30–35%. Also in 2025, Cytiva introduced a new high‑flow mixed‑mode variant specifically engineered for continuous‑flow downstream processes, targeting titers above 8 g/L and enabling unattended runs for 12–14 hours per cycle. These developments underscore how leading manufacturers are tailoring their Mixed‑Mode Chromatography Resin portfolios to the evolving demands of high‑titer, high‑throughput biomanufacturing, further consolidating their positions in the Mixed‑Mode Chromatography Resin Market.

“Mixed-Mode Chromatography Resin Production Data and Mixed-Mode Chromatography Resin Production Trend, Mixed-Mode Chromatography Resin Production Database and forecast”

• • • Mixed-Mode Chromatography Resin production database for historical years, 12 years historical data
    • Mixed-Mode Chromatography Resin production data and forecast for next 8 years